Clinical Trials in Pennsylvania

Showing 8941-8960 of 14,950 trials

Comprehensive CBT (Cognitive Behavioral Therapy) Via reSET App

NCT03826966

This research is being done to find out whether an app based cognitive behavior therapy called reSET improves the adherence to and outcome of buprenorphine treatment for opioid use disorder (OUD) in the setting of a Hub and Spoke implementation system.

AddictionOpioid-use Disorder

Milton S. Hershey Medical Center15 participantsStarted Mar 2019

Harrisburg, Pennsylvania, United States

No Longer Available36 miles

Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy

NCT02624570

The purpose of this study is to provide access to Midostaurin and gather additional safety data on the combination of Midostaurin and standard of care for adult patients with newly diagnosed Fms-like tyrosine kinase receptor (FLT3) mutated Acute Myeloid Leukemia (AML) who are eligible for standard induction and consolidation chemotherapy.

Acute Myeloid Leukemia (AML) WithFLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)

Novartis Pharmaceuticals

Phoenix, Arizona, United States • Berkeley, California, United States • Duarte, California, United States +41 more locations

Comprehensive CBT (Cognitive Behavioral Therapy) Via reSET App

Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy

Find Trials by Condition in Pennsylvania

Prognostic Factors Associated With Postoperative Cognitive Dysfunction After Surgery

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment

Growth and Tolerance of Infants Fed Formula for 16 Weeks

Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)

Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

Intra-oral Treatment of OLP With Rivelin®-CLO Patches

Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Bronchial Thermoplasty 10+ Year Study

Measuring and Improving Coproduction Using coopeRATE

Advanced Endoscopy During COVID-19

ACR | LAB Urine Analysis Test System Evaluation of Performance

Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)

Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis

Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR